|
NASP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.080300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.379000E-01 |
| Normal-vs-Stage2 |
6.307400E-01 |
| Normal-vs-Stage3 |
6.831600E-01 |
| Normal-vs-Stage4 |
6.799800E-01 |
| Stage1-vs-Stage2 |
7.296000E-01 |
| Stage1-vs-Stage3 |
5.063600E-01 |
| Stage1-vs-Stage4 |
7.636200E-01 |
| Stage2-vs-Stage3 |
8.657600E-01 |
| Stage2-vs-Stage4 |
9.777200E-01 |
| Stage3-vs-Stage4 |
9.146000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.664200E-02 |
| Normal-vs-AfricanAmerican |
2.868600E-01 |
| Normal-vs-Asian |
1.992560E-01 |
| Caucasian-vs-AfricanAmerican |
5.067200E-01 |
| Caucasian-vs-Asian |
7.951800E-01 |
| AfricanAmerican-vs-Asian |
5.893000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.844400E-02 |
| Normal-vs-Female |
4.945800E-02 |
| Male-vs-Female |
5.215200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.112600E-01 |
| Normal-vs-Extreme_Weight |
1.580560E-01 |
| Normal-vs-Obese |
8.823600E-02 |
| Normal-vs-Extreme_Obese |
8.073400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.851400E-01 |
| Normal_Weight-vs-Obese |
7.881800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.633800E-01 |
| Extreme_Weight-vs-Obese |
7.485600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.730400E-01 |
| Obese-vs-Extreme_Obese |
2.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.416500E-02 |
| Normal-vs-Age(41-60Yrs) |
5.222500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.437820E-01 |
| Normal-vs-Age(81-100Yrs) |
6.336400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.417400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.162400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.631600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.256400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.306500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.388200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.982800E-03 |
| Normal-VS-Type2 PRCC |
3.765900E-02 |
| Normal-VS-KIRP CIMP |
9.200100E-03 |
| Normal-VS-Unclassified PRCC |
4.147400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.40979458610013E-11 |
| Type1 PRCC-VS-KIRP CIMP |
4.719000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.788100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.389800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.376300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.042450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.959600E-01 |
| Normal-vs-N1 |
4.450000E-02 |
| Normal-vs-N2 |
7.914200E-01 |
| N0-vs-N1 |
4.567600E-02 |
| N0-vs-N2 |
9.049400E-01 |
| N1-vs-N2 |
4.646200E-01 |
|
|
